The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Animal Pharmaceutical Market Research Report 2025
Synopsis
The global Animal Pharmaceutical market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 25%.
This report aims to provide a comprehensive presentation of the global market for Animal Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Pharmaceutical.
Report Scope
The Animal Pharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Pharmaceutical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Merial
Elanco
Bayer Animal Health
Boehringer Ingelheim Vetmedica
Virbac
Ceva Sante Animale
Vétoquinol
Jurox
MSD Animal Health Australia
PARNELL
CAHIC
Ringpu Biology
Segment by Type
Vaccine
Veterinary Drugs
Other
Segment by Application
Companion Animal
Poultry
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal Pharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal Pharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Animal Pharmaceutical market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 25%.
This report aims to provide a comprehensive presentation of the global market for Animal Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Pharmaceutical.
Report Scope
The Animal Pharmaceutical market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Animal Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Pharmaceutical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Merial
Elanco
Bayer Animal Health
Boehringer Ingelheim Vetmedica
Virbac
Ceva Sante Animale
Vétoquinol
Jurox
MSD Animal Health Australia
PARNELL
CAHIC
Ringpu Biology
Segment by Type
Vaccine
Veterinary Drugs
Other
Segment by Application
Companion Animal
Poultry
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Animal Pharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Animal Pharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Animal Pharmaceutical Market Overview
1.1 Product Overview and Scope of Animal Pharmaceutical
1.2 Animal Pharmaceutical Segment by Type
1.2.1 Global Animal Pharmaceutical Market Value Comparison by Type (2024-2030)
1.2.2 Vaccine
1.2.3 Veterinary Drugs
1.2.4 Other
1.3 Animal Pharmaceutical Segment by Application
1.3.1 Global Animal Pharmaceutical Market Value by Application: (2024-2030)
1.3.2 Companion Animal
1.3.3 Poultry
1.3.4 Other
1.4 Global Animal Pharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Animal Pharmaceutical Revenue 2019-2030
1.4.2 Global Animal Pharmaceutical Sales 2019-2030
1.4.3 Global Animal Pharmaceutical Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Animal Pharmaceutical Market Competition by Manufacturers
2.1 Global Animal Pharmaceutical Sales Market Share by Manufacturers (2019-2024)
2.2 Global Animal Pharmaceutical Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Animal Pharmaceutical Average Price by Manufacturers (2019-2024)
2.4 Global Animal Pharmaceutical Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Animal Pharmaceutical, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal Pharmaceutical, Product Type & Application
2.7 Animal Pharmaceutical Market Competitive Situation and Trends
2.7.1 Animal Pharmaceutical Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Animal Pharmaceutical Players Market Share by Revenue
2.7.3 Global Animal Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Animal Pharmaceutical Retrospective Market Scenario by Region
3.1 Global Animal Pharmaceutical Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Animal Pharmaceutical Global Animal Pharmaceutical Sales by Region: 2019-2030
3.2.1 Global Animal Pharmaceutical Sales by Region: 2019-2024
3.2.2 Global Animal Pharmaceutical Sales by Region: 2025-2030
3.3 Global Animal Pharmaceutical Global Animal Pharmaceutical Revenue by Region: 2019-2030
3.3.1 Global Animal Pharmaceutical Revenue by Region: 2019-2024
3.3.2 Global Animal Pharmaceutical Revenue by Region: 2025-2030
3.4 North America Animal Pharmaceutical Market Facts & Figures by Country
3.4.1 North America Animal Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Animal Pharmaceutical Sales by Country (2019-2030)
3.4.3 North America Animal Pharmaceutical Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Animal Pharmaceutical Market Facts & Figures by Country
3.5.1 Europe Animal Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Animal Pharmaceutical Sales by Country (2019-2030)
3.5.3 Europe Animal Pharmaceutical Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal Pharmaceutical Market Facts & Figures by Country
3.6.1 Asia Pacific Animal Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Animal Pharmaceutical Sales by Country (2019-2030)
3.6.3 Asia Pacific Animal Pharmaceutical Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Animal Pharmaceutical Market Facts & Figures by Country
3.7.1 Latin America Animal Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Animal Pharmaceutical Sales by Country (2019-2030)
3.7.3 Latin America Animal Pharmaceutical Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal Pharmaceutical Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal Pharmaceutical Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Animal Pharmaceutical Sales by Country (2019-2030)
3.8.3 Middle East and Africa Animal Pharmaceutical Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Animal Pharmaceutical Sales by Type (2019-2030)
4.1.1 Global Animal Pharmaceutical Sales by Type (2019-2024)
4.1.2 Global Animal Pharmaceutical Sales by Type (2025-2030)
4.1.3 Global Animal Pharmaceutical Sales Market Share by Type (2019-2030)
4.2 Global Animal Pharmaceutical Revenue by Type (2019-2030)
4.2.1 Global Animal Pharmaceutical Revenue by Type (2019-2024)
4.2.2 Global Animal Pharmaceutical Revenue by Type (2025-2030)
4.2.3 Global Animal Pharmaceutical Revenue Market Share by Type (2019-2030)
4.3 Global Animal Pharmaceutical Price by Type (2019-2030)
5 Segment by Application
5.1 Global Animal Pharmaceutical Sales by Application (2019-2030)
5.1.1 Global Animal Pharmaceutical Sales by Application (2019-2024)
5.1.2 Global Animal Pharmaceutical Sales by Application (2025-2030)
5.1.3 Global Animal Pharmaceutical Sales Market Share by Application (2019-2030)
5.2 Global Animal Pharmaceutical Revenue by Application (2019-2030)
5.2.1 Global Animal Pharmaceutical Revenue by Application (2019-2024)
5.2.2 Global Animal Pharmaceutical Revenue by Application (2025-2030)
5.2.3 Global Animal Pharmaceutical Revenue Market Share by Application (2019-2030)
5.3 Global Animal Pharmaceutical Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Animal Pharmaceutical Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Animal Pharmaceutical Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Merial
6.3.1 Merial Corporation Information
6.3.2 Merial Description and Business Overview
6.3.3 Merial Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merial Animal Pharmaceutical Product Portfolio
6.3.5 Merial Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Animal Pharmaceutical Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Bayer Animal Health
6.5.1 Bayer Animal Health Corporation Information
6.5.2 Bayer Animal Health Description and Business Overview
6.5.3 Bayer Animal Health Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Animal Health Animal Pharmaceutical Product Portfolio
6.5.5 Bayer Animal Health Recent Developments/Updates
6.6 Boehringer Ingelheim Vetmedica
6.6.1 Boehringer Ingelheim Vetmedica Corporation Information
6.6.2 Boehringer Ingelheim Vetmedica Description and Business Overview
6.6.3 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product Portfolio
6.6.5 Boehringer Ingelheim Vetmedica Recent Developments/Updates
6.7 Virbac
6.6.1 Virbac Corporation Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Virbac Animal Pharmaceutical Product Portfolio
6.7.5 Virbac Recent Developments/Updates
6.8 Ceva Sante Animale
6.8.1 Ceva Sante Animale Corporation Information
6.8.2 Ceva Sante Animale Description and Business Overview
6.8.3 Ceva Sante Animale Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ceva Sante Animale Animal Pharmaceutical Product Portfolio
6.8.5 Ceva Sante Animale Recent Developments/Updates
6.9 Vétoquinol
6.9.1 Vétoquinol Corporation Information
6.9.2 Vétoquinol Description and Business Overview
6.9.3 Vétoquinol Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vétoquinol Animal Pharmaceutical Product Portfolio
6.9.5 Vétoquinol Recent Developments/Updates
6.10 Jurox
6.10.1 Jurox Corporation Information
6.10.2 Jurox Description and Business Overview
6.10.3 Jurox Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jurox Animal Pharmaceutical Product Portfolio
6.10.5 Jurox Recent Developments/Updates
6.11 MSD Animal Health Australia
6.11.1 MSD Animal Health Australia Corporation Information
6.11.2 MSD Animal Health Australia Animal Pharmaceutical Description and Business Overview
6.11.3 MSD Animal Health Australia Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MSD Animal Health Australia Animal Pharmaceutical Product Portfolio
6.11.5 MSD Animal Health Australia Recent Developments/Updates
6.12 PARNELL
6.12.1 PARNELL Corporation Information
6.12.2 PARNELL Animal Pharmaceutical Description and Business Overview
6.12.3 PARNELL Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.12.4 PARNELL Animal Pharmaceutical Product Portfolio
6.12.5 PARNELL Recent Developments/Updates
6.13 CAHIC
6.13.1 CAHIC Corporation Information
6.13.2 CAHIC Animal Pharmaceutical Description and Business Overview
6.13.3 CAHIC Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CAHIC Animal Pharmaceutical Product Portfolio
6.13.5 CAHIC Recent Developments/Updates
6.14 Ringpu Biology
6.14.1 Ringpu Biology Corporation Information
6.14.2 Ringpu Biology Animal Pharmaceutical Description and Business Overview
6.14.3 Ringpu Biology Animal Pharmaceutical Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Ringpu Biology Animal Pharmaceutical Product Portfolio
6.14.5 Ringpu Biology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal Pharmaceutical Industry Chain Analysis
7.2 Animal Pharmaceutical Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal Pharmaceutical Production Mode & Process
7.4 Animal Pharmaceutical Sales and Marketing
7.4.1 Animal Pharmaceutical Sales Channels
7.4.2 Animal Pharmaceutical Distributors
7.5 Animal Pharmaceutical Customers
8 Animal Pharmaceutical Market Dynamics
8.1 Animal Pharmaceutical Industry Trends
8.2 Animal Pharmaceutical Market Drivers
8.3 Animal Pharmaceutical Market Challenges
8.4 Animal Pharmaceutical Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Animal Pharmaceutical Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Animal Pharmaceutical Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Animal Pharmaceutical Market Competitive Situation by Manufacturers in 2023
Table 4. Global Animal Pharmaceutical Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Animal Pharmaceutical Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Animal Pharmaceutical Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Animal Pharmaceutical Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Animal Pharmaceutical Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Animal Pharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Animal Pharmaceutical, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Animal Pharmaceutical, Product Type & Application
Table 12. Global Key Manufacturers of Animal Pharmaceutical, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Animal Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Pharmaceutical as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Animal Pharmaceutical Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Animal Pharmaceutical Sales by Region (2019-2024) & (K MT)
Table 18. Global Animal Pharmaceutical Sales Market Share by Region (2019-2024)
Table 19. Global Animal Pharmaceutical Sales by Region (2025-2030) & (K MT)
Table 20. Global Animal Pharmaceutical Sales Market Share by Region (2025-2030)
Table 21. Global Animal Pharmaceutical Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Animal Pharmaceutical Revenue Market Share by Region (2019-2024)
Table 23. Global Animal Pharmaceutical Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Animal Pharmaceutical Revenue Market Share by Region (2025-2030)
Table 25. North America Animal Pharmaceutical Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Animal Pharmaceutical Sales by Country (2019-2024) & (K MT)
Table 27. North America Animal Pharmaceutical Sales by Country (2025-2030) & (K MT)
Table 28. North America Animal Pharmaceutical Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Animal Pharmaceutical Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Animal Pharmaceutical Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Animal Pharmaceutical Sales by Country (2019-2024) & (K MT)
Table 32. Europe Animal Pharmaceutical Sales by Country (2025-2030) & (K MT)
Table 33. Europe Animal Pharmaceutical Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Animal Pharmaceutical Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Animal Pharmaceutical Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Animal Pharmaceutical Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Animal Pharmaceutical Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Animal Pharmaceutical Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Animal Pharmaceutical Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Animal Pharmaceutical Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Animal Pharmaceutical Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Animal Pharmaceutical Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Animal Pharmaceutical Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Animal Pharmaceutical Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Animal Pharmaceutical Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Animal Pharmaceutical Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Animal Pharmaceutical Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Animal Pharmaceutical Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Animal Pharmaceutical Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Animal Pharmaceutical Sales (K MT) by Type (2019-2024)
Table 51. Global Animal Pharmaceutical Sales (K MT) by Type (2025-2030)
Table 52. Global Animal Pharmaceutical Sales Market Share by Type (2019-2024)
Table 53. Global Animal Pharmaceutical Sales Market Share by Type (2025-2030)
Table 54. Global Animal Pharmaceutical Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Animal Pharmaceutical Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Animal Pharmaceutical Revenue Market Share by Type (2019-2024)
Table 57. Global Animal Pharmaceutical Revenue Market Share by Type (2025-2030)
Table 58. Global Animal Pharmaceutical Price (USD/MT) by Type (2019-2024)
Table 59. Global Animal Pharmaceutical Price (USD/MT) by Type (2025-2030)
Table 60. Global Animal Pharmaceutical Sales (K MT) by Application (2019-2024)
Table 61. Global Animal Pharmaceutical Sales (K MT) by Application (2025-2030)
Table 62. Global Animal Pharmaceutical Sales Market Share by Application (2019-2024)
Table 63. Global Animal Pharmaceutical Sales Market Share by Application (2025-2030)
Table 64. Global Animal Pharmaceutical Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Animal Pharmaceutical Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Animal Pharmaceutical Revenue Market Share by Application (2019-2024)
Table 67. Global Animal Pharmaceutical Revenue Market Share by Application (2025-2030)
Table 68. Global Animal Pharmaceutical Price (USD/MT) by Application (2019-2024)
Table 69. Global Animal Pharmaceutical Price (USD/MT) by Application (2025-2030)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Zoetis Animal Pharmaceutical Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Merck Animal Pharmaceutical Product
Table 79. Merck Recent Developments/Updates
Table 80. Merial Corporation Information
Table 81. Merial Description and Business Overview
Table 82. Merial Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Merial Animal Pharmaceutical Product
Table 84. Merial Recent Developments/Updates
Table 85. Elanco Corporation Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Elanco Animal Pharmaceutical Product
Table 89. Elanco Recent Developments/Updates
Table 90. Bayer Animal Health Corporation Information
Table 91. Bayer Animal Health Description and Business Overview
Table 92. Bayer Animal Health Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Bayer Animal Health Animal Pharmaceutical Product
Table 94. Bayer Animal Health Recent Developments/Updates
Table 95. Boehringer Ingelheim Vetmedica Corporation Information
Table 96. Boehringer Ingelheim Vetmedica Description and Business Overview
Table 97. Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product
Table 99. Boehringer Ingelheim Vetmedica Recent Developments/Updates
Table 100. Virbac Corporation Information
Table 101. Virbac Description and Business Overview
Table 102. Virbac Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Virbac Animal Pharmaceutical Product
Table 104. Virbac Recent Developments/Updates
Table 105. Ceva Sante Animale Corporation Information
Table 106. Ceva Sante Animale Description and Business Overview
Table 107. Ceva Sante Animale Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Ceva Sante Animale Animal Pharmaceutical Product
Table 109. Ceva Sante Animale Recent Developments/Updates
Table 110. Vétoquinol Corporation Information
Table 111. Vétoquinol Description and Business Overview
Table 112. Vétoquinol Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Vétoquinol Animal Pharmaceutical Product
Table 114. Vétoquinol Recent Developments/Updates
Table 115. Jurox Corporation Information
Table 116. Jurox Description and Business Overview
Table 117. Jurox Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Jurox Animal Pharmaceutical Product
Table 119. Jurox Recent Developments/Updates
Table 120. MSD Animal Health Australia Corporation Information
Table 121. MSD Animal Health Australia Description and Business Overview
Table 122. MSD Animal Health Australia Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. MSD Animal Health Australia Animal Pharmaceutical Product
Table 124. MSD Animal Health Australia Recent Developments/Updates
Table 125. PARNELL Corporation Information
Table 126. PARNELL Description and Business Overview
Table 127. PARNELL Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. PARNELL Animal Pharmaceutical Product
Table 129. PARNELL Recent Developments/Updates
Table 130. CAHIC Corporation Information
Table 131. CAHIC Description and Business Overview
Table 132. CAHIC Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 133. CAHIC Animal Pharmaceutical Product
Table 134. CAHIC Recent Developments/Updates
Table 135. Ringpu Biology Corporation Information
Table 136. Ringpu Biology Description and Business Overview
Table 137. Ringpu Biology Animal Pharmaceutical Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 138. Ringpu Biology Animal Pharmaceutical Product
Table 139. Ringpu Biology Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Animal Pharmaceutical Distributors List
Table 143. Animal Pharmaceutical Customers List
Table 144. Animal Pharmaceutical Market Trends
Table 145. Animal Pharmaceutical Market Drivers
Table 146. Animal Pharmaceutical Market Challenges
Table 147. Animal Pharmaceutical Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Animal Pharmaceutical
Figure 2. Global Animal Pharmaceutical Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Animal Pharmaceutical Market Share by Type in 2023 & 2030
Figure 4. Vaccine Product Picture
Figure 5. Veterinary Drugs Product Picture
Figure 6. Other Product Picture
Figure 7. Global Animal Pharmaceutical Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Animal Pharmaceutical Market Share by Application in 2023 & 2030
Figure 9. Companion Animal
Figure 10. Poultry
Figure 11. Other
Figure 12. Global Animal Pharmaceutical Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Animal Pharmaceutical Market Size (2019-2030) & (US$ Million)
Figure 14. Global Animal Pharmaceutical Sales (2019-2030) & (K MT)
Figure 15. Global Animal Pharmaceutical Average Price (USD/MT) & (2019-2030)
Figure 16. Animal Pharmaceutical Report Years Considered
Figure 17. Animal Pharmaceutical Sales Share by Manufacturers in 2023
Figure 18. Global Animal Pharmaceutical Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Animal Pharmaceutical Players: Market Share by Revenue in 2023
Figure 20. Animal Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Animal Pharmaceutical Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Animal Pharmaceutical Sales Market Share by Country (2019-2030)
Figure 23. North America Animal Pharmaceutical Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Animal Pharmaceutical Sales Market Share by Country (2019-2030)
Figure 27. Europe Animal Pharmaceutical Revenue Market Share by Country (2019-2030)
Figure 28. Germany Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Animal Pharmaceutical Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Animal Pharmaceutical Revenue Market Share by Region (2019-2030)
Figure 35. China Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Animal Pharmaceutical Sales Market Share by Country (2019-2030)
Figure 45. Latin America Animal Pharmaceutical Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Animal Pharmaceutical Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Animal Pharmaceutical Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Animal Pharmaceutical Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Animal Pharmaceutical by Type (2019-2030)
Figure 55. Global Revenue Market Share of Animal Pharmaceutical by Type (2019-2030)
Figure 56. Global Animal Pharmaceutical Price (USD/MT) by Type (2019-2030)
Figure 57. Global Sales Market Share of Animal Pharmaceutical by Application (2019-2030)
Figure 58. Global Revenue Market Share of Animal Pharmaceutical by Application (2019-2030)
Figure 59. Global Animal Pharmaceutical Price (USD/MT) by Application (2019-2030)
Figure 60. Animal Pharmaceutical Value Chain
Figure 61. Animal Pharmaceutical Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
